With artificial intelligence making deep inroads into healthcare, two top doctors are urging physicians to embrace the technology but to remember that only humans can serve the best interest of individual patients.

14 Oct 2026

Novel gene rejuvenation therapy preserves cell identity while reversing age

Every organ and tissue progressively loses function and integrity as it ages. In fact, researchers have identified "hallmarks of aging" that not only present specific processes impacted by age, but are also thought of as levers that, if successfully targeted, could help turn back the aging clock and result in tissue rejuvenation.

14 Oct 2026

Opioid use disorder diagnoses spike among commercially insured Americans

Commercially insured patients with diagnoses of opioid use disorder increased 32.7 percent nationally from 2022 to 2025, according to FAIR Health's Opioid Tracker.

14 Oct 2026

Early vasopressin use does not improve septic shock survival

A new study from researchers at Intermountain Health in Salt Lake City found that starting an advanced medication earlier for critically ill patients with life-threatening septic shock does not improve their survival, shorten hospital stays, or improve their recovery compared with waiting until their condition potentially worsens.

14 Oct 2026

Finnish study finds poor oral health increases jawbone necrosis risks in breast cancer patients

Antiresorptive drugs, which reduce bone breakdown, are an important part of treatment for breast cancer that has spread to the bones. However, their use can be associated with osteonecrosis of the jaw (MRONJ), a condition in which bone tissue in the jaw dies.

14 Oct 2026

Improving healthcare sustainability through carbon data

Healthcare sustainability data can identify emissions hotspots and improve operational decision-making across healthcare and life sciences.

From Nocomed 14 Oct 2026

Seragy launches with €12 million financing to advance quantitative biomarkers for neurodegenerative diseases

seragy holding GmbH (formerly Prosperodes GmbH), a biomarker strategy company focused on neurodegenerative diseases and other proteopathies, has secured €12 million in funding to accelerate the development of its SeRAS® platform (Seed Replication, Analysis and Subtyping) and expand its laboratory and analytical capabilities. The financing is backed by Commerzbank, the Mittelständische Beteiligungsgesellschaft (MBG), and the State of Lower Saxony.

14 Oct 2026

Nature-based activities may offer lasting relief from loneliness

About one in three Americans and one in six people worldwide feel lonely on a regular basis, a troubling reality that has prompted some public health officials to declare an "epidemic of loneliness."

13 Oct 2026

CHOP researchers link MAP2K4 variants to a neurodevelopmental disorder

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the mechanisms of previously unknown changes in a gene that result in symptoms associated with a neurodevelopmental disorder.

13 Oct 2026

ACLM launches resources to meet new medical nutrition requirements

The American College of Lifestyle Medicine (ACLM) has launched two resources to help medical schools meet new federal nutrition requirements and to support practicing physicians seeking education relevant to state-level nutrition education requirements.

13 Oct 2026

Replacement chemical for harmful phthalates may restrict fetal growth

A chemical used to make plastic more flexible, once introduced as a safer substitute for older additives now known to be harmful, may itself also be harmful, slowing babies' growth in the womb, a new study shows.

13 Oct 2026

Light-activated cotton fabric reduces harmful microorganisms in hospital rooms

A team from the Alcoy campus of the Universitat Politècnica de València (UPV), the Research Institute for Chemical Technology (ITQ, CSIC-UPV), the Research Institute for Mediterranean Agroforestry (IAM UPV) and the Joint Research Unit between the UPV and the Health Research Institute at La Fe Hospital in Valencia (UPV-IISLaFe) has developed a new self-disinfecting cotton fabric capable of eliminating bacteria, fungi and viruses in hospital settings using visible light.

13 Oct 2026

New AI tool detects early psychosis risk in youth speech

Nanyang Technological University, Singapore (NTU Singapore) and the Institute of Mental Health (IMH) have developed a novel artificial intelligence (AI) framework capable of identifying youths at high risk of psychosis - a severe mental health condition that typically emerges in adolescence to early adulthood where a person may experience hallucinations, delusions, and disordered thinking - from short samples of casual, spontaneous speech.

13 Oct 2026

Bedfont® Scientific Ltd. acquires US-based company coVita™, marking the next chapter in its global growth

Bedfont®, a world leader in breath analysis, announces its acquisition of coVita™, building on 16 years of partnership, market knowledge, and established infrastructure to support global expansion.

From Bedfont® Scientific Ltd 13 Oct 2026

Nearly 400,000 adults, six body measurements, and a surprising result for heart attack risk

A UK Biobank study involving 395,831 adults found that a higher body roundness index (BRI) was associated with an increased risk of myocardial infarction over a median follow-up of 13.3 years. BRI showed slightly better predictive performance than BMI and four other anthropometric measures, although the improvements were modest and require independent validation before clinical adoption.

13 Oct 2026

ADHD diagnoses rise as awareness improves across Europe, experts say

ADHD seems to be in the news everywhere, but is this due to a rise in cases or to changing awareness and diagnosis?

12 Oct 2026

Women with autoimmune diseases more likely to receive psychiatric misdiagnoses

Females with autoimmune diseases are significantly more likely than males to have their autoimmune disease misdiagnosed as a psychiatric or psychosomatic condition, according to a study of more than 6,600 patients.

12 Oct 2026

Oregon's licensed psilocybin centers prioritize safety but remain highly expensive

A new study has found that Oregon's licensed psilocybin centers largely follow recommended safety guidelines, offering reassurance about how the first regulated psilocybin programs in the U.S. function in practice - though the cost of treatment may keep it out of reach for many.

12 Oct 2026

New study tracks how eating behaviors vary with age, sex and body weight

Eating behavior varies with age and body weight. A University of Oulu study found that emotional and uncontrolled eating are more pronounced in younger adults, while cognitive restraint is more common among older people. Sex and body weight also influence which eating behaviors are typical.

12 Oct 2026

Systemic failures protect medical professionals who commit serious crimes

Institutional fear of litigation, reputation damage and career consequences can create a protective shield around the small minority of doctors who commit serious crimes against patients, experts warn.

12 Oct 2026